Eastwood Bio-Medical Canada Inc. announced earnings results for the third quarter ended July 31, 2020. For the third quarter, the company announced total revenue was CAD 184,854 compared to CAD 211,250 a year ago. Net loss was CAD 73,381 compared to CAD 106,231 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. For the nine months, total revenue was CAD 515,297 compared to CAD 1.009 million a year ago. Net loss was CAD 576,179 compared to CAD 389,623 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.